Patents
Patents for C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
09/2002
09/17/2002CA2223293C Process for the preparation of 1,2-dioxetane compounds and novel sulfur-substituted 1,2-dioxetane compounds as intermediates
09/12/2002WO2002070541A2 Peptide deformylase inhibitors
09/12/2002CA2439827A1 Peptide deformylase inhibitors
09/11/2002CN1090629C Novel Heterocyclic compounds
08/2002
08/22/2002US20020115654 New compounds, their preparation and use
08/08/2002US20020106687 Dioxetane probes for use as signaling tool in biological analysis
08/08/2002DE10105313A1 Verfahren zur Herstellung von Verbindungen mit einer CF20-Brücke Process for the preparation of compounds having a bridge-CF20
08/07/2002CN1362963A 3-deoxy-desmycosin derivatives and process for their preparation
08/01/2002US20020102624 Kit for conducting an assay to detect a substance using enzymatically-induced decomposition of dioxetanes
07/2002
07/24/2002EP1019390B1 1,2 chemiluminescent dioxetanes of improved performance
07/18/2002US20020095045 Thermal cleavage of macrocyclic esters in the presence of a thermostable benzene derivative
07/17/2002EP0851865B1 12H-Dibenzo[d,g][1,3]dioxocine derivatives
07/10/2002EP1220850A2 1,4-dioxacycloalkane-2-one and 1,4-dioxacycloalkene-2-one
07/09/2002US6417380 Polycycloalkyl ketone containing fluorescent chromophore is alkylated to polycycloalkylidene ether in presence of alkali metal alkoxide in polar aprotic solvent
07/03/2002EP1218368A1 COMPOSITIONS AND METHODS FOR MODULATING APOPTOSIS IN CELLS OVER-EXPRESSING bcl-2 FAMILY MEMBER PROTEINS
07/03/2002EP1077912B1 Novel derivatives of 3,3-diphenylpropylamines
06/2002
06/27/2002WO2002049632A1 Inhibitors against the production and release of inflammatory cytokines
06/27/2002WO2001081276A3 Method for producing ketal and/or acetal
06/25/2002US6410751 Water soluble tri-substituted 1, 2-dioxetane compounds having increased storage stability, synthetic processes and intermediates
06/20/2002WO2002048073A1 Method for producing compounds having a cf2o bridge
06/19/2002CN1354737A Novel derivatives of 3-3-diphenylpropylamines
06/18/2002US6407127 3-(4-(2-(5h-dibenzo(a,d)cyclohepten-5-yloxy)-ethoxyl-phenyl)-2 -ethoxy-propionic acid ethyl ester as antidiabetic agents and to treat obesity
06/18/2002US6407100 Fungicidal aromatic oximes
06/06/2002US20020068723 Altering the conformational equilibrium of the A- ring to favor a chair conformation that presents the 1 alpha-hydroxyl in the axial orientation.
05/2002
05/29/2002EP0790991B1 Novel 1,2-dioxetane compounds with haloalkoxy groups, methods of preparation and use
05/23/2002WO2002040492A1 Chiral diphosphines and their metal complexes
05/23/2002WO2002016345A3 Method for the production of macrocyclic esters
05/23/2002CA2429252A1 Chiral diphosphines and their metal complexes
05/22/2002EP1053215B1 Methods for preparing macrocyclic products by ring-closing diine metathesis
05/16/2002US20020056827 Piezoelectric element and process for production thereof
05/09/2002US20020055653 Diphosphines
05/07/2002US6384289 Reacting a 1,4-bis/1,3-dioxa-, dithia- or oxathia- 4,5, or 6-member cycloalk-2-yl/benzene, a fluorinating compound and a bromine-containing compound in a solvent at low temperatures; simplification
05/02/2002WO2002034740A1 Method for producing cyclic carboxylic orthoester fluorides and corresponding compounds
05/02/2002WO2002034739A1 Chiral binaphthol derivatives
04/2002
04/30/2002US6379658 Consisting of beta-naphthyl methyl ether, beta-naphthyl ketone, benzyl acetone, hexahydro-4,7-methanoinden-5-yl and 6-yl propionates, gamma-methyl ionone, furan derivative, 3,7-dimethyl-2,6-nonadien-1-nitrile, cyclic ester, ketone
04/30/2002CA2059787C Hydrazine derivative and pesticidal composition comprising said derivative as an effective ingredient
04/25/2002US20020049337 4-(2-amino-1-hydroxyethyl)oxazoline derivative and method for producing same
04/17/2002EP1196406A1 Amino ceramide-like compounds and therapeutic methods of use
04/09/2002US6369099 Method of locking 1 α-OH of vitamin D compounds in axial orientation
04/04/2002WO2002026856A1 Twisted polymers, uses thereof and processes for the preparation of statistical copolymers
04/04/2002DE10044793A1 Diphosphine Diphosphines
04/03/2002EP0736174B1 Chemiluminescent energy transfer assays
03/2002
03/27/2002EP1191611A2 Piezoelectric element and process for production thereof
03/14/2002DE10041198A1 Verfahren zur Herstellung makrocyclischer Ester A process for the preparation of macrocyclic esters
03/13/2002EP1186609A2 Diphosphines
03/12/2002US6355634 Aromatic compounds
03/11/2002CA2357261A1 Diphosphines
03/05/2002US6353129 Water soluble tri-substituted 1,2-dioxetane compounds having increased storage stability, synthetic processes and intermediates
03/05/2002US6353019 Anticancer drugs
03/05/2002US6353018 Compounds, their preparation and use
02/2002
02/28/2002WO2002016345A2 Method for the production of macrocyclic esters
02/20/2002EP0842168B1 Process for the preparation of 1,2-dioxetane compounds and novel sulfur-substituted 1,2-dioxetane compounds as intermediates
02/19/2002US6348551 Selective olefin metathesis of bifunctional or polyfunctional substrates in compressed carbon dioxide as reaction medium
02/14/2002US20020019553 Chemiluminescence
02/13/2002CN1335312A Method of purifying macrocyclic ester compound of musk
02/12/2002US6346615 Spiroadamantyl dioxetanes bearing an alkoxy substituent, and an aromatic substituent on the dioxetane ring can be activated to chemiluminesce if the aromatic substituent bears a moiety that is cleaved by an enzyme
02/06/2002CN1334798A Phenylglycine derivatives
01/2002
01/30/2002EP1175428A1 3-deoxy-desmycosin derivatives and process for their preparation
01/30/2002EP0689611B1 Improved enhancement of chemiluminescent assays
01/23/2002EP1173429A1 Protease inhibitors
01/17/2002US20020006917 Method of locking 1alpha-OH of vitamin D compounds in axial orientation
01/16/2002EP0666891B1 Chemiluminescent electron-rich aryl-substituted 1,2-dioxetanes
01/03/2002WO2002000590A1 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis
12/2001
12/25/2001US6333416 Chemical intermediate for protease inhibitor
12/20/2001WO2000066602A9 3-deoxy-desmycosin derivatives and process for their preparation
12/18/2001CA2035029C Synthesis of stable water-soluble chemiluminescent 1,2-dioxetanes and intermediates therefor
12/12/2001EP1161237A1 Protease inhibitors
12/12/2001EP0917526B1 use of polyacids to treat mineral fertilizers containing a nitrification inhibitor
11/2001
11/29/2001US20010046982 Internal 1, 15-lactones of fluprostenol and related prostaglandin F2a analogs and their use in the treatment of glaucoma and intraocular hypertension
11/27/2001US6322727 Kit for conducting an assay to detect a substance using enzymatically-induced decomposition of dioxetanes
11/22/2001US20010044407 1,2-substituted 2,3-dihydro-1H-5,9-dioxacyclohepta [ f ] inden -7- ones and 7-substituted benzo [ b ] [ 1,4 ] dioxepin -3-ones
11/01/2001WO2001081276A2 Method for producing ketal and/or acetal
10/2001
10/31/2001EP1149069A1 Phenylglycine derivatives
10/31/2001CN1319598A 1,2-substituted 2,3-dihydro-1H-5,9-dioxide heterocyclic heptyl and [f] indine-8-ketone and 7-substituted benzo [b][1,4] dioxide heterocyclic heptyl-1-ketone
10/24/2001EP0906295B1 Dibenzo-oxazepine and -dioxepine derivatives and their use as anti-tumor agents
10/18/2001US20010031786 Antidiabetic agents, obesity
10/18/2001US20010031764 3-(4-(2-(5h-dibenzo(a,d)cyclohepten-5-yloxy)-ethoxyl-phenyl)-2 -ethoxy-propionic acid ethyl ester as antidiabetic agents and to treat obesity
10/18/2001US20010031762 3-(4-(2-(5h-dibenzo(a,d)cyclohepten-5-yloxy)-ethoxyl-phenyl)-2 -ethoxy-propionic acid ethyl ester as antidiabetic agents and to treat obesity
10/11/2001US20010029256 Peroxisome proliferator activator receptor; dietetics, antidiabetic agents
10/10/2001CN1072665C Preparation of unsaturated cyclic ethers
10/10/2001CN1072650C Bibenzo-oxazepine and -dioxepine derivatives and their use as anti-tumor agent
10/03/2001CN1072217C Process for producing 2-substituted-3,4-condensed heterocyclic benzoic acid
09/2001
09/27/2001US20010025036 Modifying the structure of a 1alpha-hydroxylated vitamin D compound to increase its in vivo activity by altering the conformational equilibrium of the A-ring to favor a chair conformation that presents 1alphahydroxy in axial orientation
09/26/2001EP1136481A1 1,2-Substituted 2,3-dihydro-1H-5,9-dioxacyclohepta[f]inden-7-ones and 7-substituted benzo[b][1,4]dioxepin-3-ones
09/26/2001CN1314881A Imidamide derivatives
09/23/2001CA2341133A1 1,2-substituted 2,3-dihydro-1h-5,9-dioxacyclohepta[f]inden-7-ones and 7-substituted benzo[b][1,4]dioxepin-3-ones
09/19/2001EP0649417B1 Improved chemiluminescent 1,2-dioxetanes
09/18/2001US6291515 Use of efomycins
09/13/2001US20010021782 Production of amide derivatives and intermediates therefor
09/11/2001US6287767 Forming enzyme complex by binding enzyme to substance; adding hydrophobic fluorescent emitter and 1,2-dioxitane compound; allowing enzyme to cleave dioxitane compound; segregating emitter and oxyanion to cause fluorescence
09/11/2001CA2057578C 1,4-disubstituted piperazines, process for their preparation and pharmaceutical compositions containing them
09/04/2001US6284899 Useful for the detection of triggering agents including enzymes.
08/2001
08/29/2001CN1070173C Benzoylaguanidine derivatives using as medicine
08/16/2001EP1123269A1 New compounds, their preparation and use
08/16/2001EP1123268A1 New compounds, their preparation and use
08/16/2001EP1123267A1 New compounds, their preparation and use
08/15/2001CN1308609A Method of locking 1 & alpha, -OH of vitamin d compounds in axial orientation
08/09/2001WO2001057015A1 INTERNAL 1,15-LACTONES OF FLUPROSTENOL AND RELATED PROSTAGLANDIN F2α ANALOGS AND THEIR USE IN THE TREATMENT OF GLAUCOMA AND INTRAOCULAR HYPERTENSION
08/01/2001EP1120652A1 Enhancement of chemiluminescence in assays
08/01/2001EP1120423A1 Improved chemiluminescent 1,2-dioxetanes
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21